Lipopolysaccharide results in a marked decrease in hepatocyte nuclear factor 4α in rat liver

被引:46
|
作者
Wang, B
Cai, SR
Gao, CH
Sladek, FM
Ponder, KP
机构
[1] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA
[3] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA
关键词
D O I
10.1053/jhep.2001.28885
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The acute-phase response can result in decreased liver-specific functions and death as a result of liver failure. We show here that lipopolysaccharide (LPS), an endotoxin that induces the acute-phase response, results in a marked decrease in the major isoforms of the transcription factor, hepatocyte nuclear factor 4 alpha (HNF-4 alpha), in livers of rats. HNF-4 alpha is a nuclear receptor that is critical for the expression of several liver-specific genes. This decrease in HNF-4 alpha is primarily the result of a posttranscriptional mechanism, because mRNA levels are normal, and there are no major changes in the splicing patterns. This decrease was of functional significance, because expression of a gene that is highly dependent on HNF-4 alpha, HNF-1 alpha, was reduced. Interleukin-1 beta (IL-1 beta) is a cytokine whose levels are increased in vivo in response to LPS. IL-1 beta resulted in a decrease in HNF-4 alpha levels in HepG2 cells. This IL-1 beta -induced decrease was likely caused by degradation via the proteasome, because it was prevented by the addition of the proteasome inhibitor, MG132. We conclude that the decrease in HNF-4 alpha that occurs in vivo after the administration of LPS may be the result of IL-1 beta -induccd degradation, and likely contributes to the liver insufficiency that occurs. IL-1 beta antagonists or proteasome inhibitors might increase HNF-4 alpha protein levels in the acute-phase response, which could result in increased liver function and survival.
引用
收藏
页码:979 / 989
页数:11
相关论文
共 50 条
  • [31] Functional domains of the nuclear receptor hepatocyte nuclear factor 4''
    HadzopoulouCladaras, M
    Kistanova, E
    Evagelopoulou, C
    Zeng, SY
    Cladaras, C
    Ladias, JAA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (01) : 539 - 550
  • [32] Suppression of Hepatocyte Proliferation by Hepatocyte Nuclear Factor 4α in Adult Mice
    Bonzo, Jessica A.
    Ferry, Christina H.
    Matsubara, Tsutomu
    Kim, Jung-Hwan
    Gonzalez, Frank J.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (10) : 7345 - 7356
  • [33] Suppression of hepatocyte nuclear factor 4α by nuclear factor κB in hepatoma cells
    Ning, Bei-Fang
    Zhang, Xin
    Xie, Wei-Fen
    CANCER RESEARCH, 2014, 74 (19)
  • [34] Hepatocyte nuclear factor 3β is an upstream regulator of the MODY1 gene hepatocyte nuclear factor 4α
    Stoffel, M
    Navas, A
    Kim, J
    Buckley, E
    Duncan, SA
    DIABETES, 1998, 47 : A16 - A16
  • [35] Role of hepatocyte nuclear factor 4 alpha (HNF4α) in hepatocyte regeneration
    Huck, Ian
    Apte, Udayan
    FASEB JOURNAL, 2017, 31
  • [36] Role of Hepatocyte Nuclear Factor 4 Alpha (HNF4α) in Hepatocyte Regeneration
    Huck, Ian
    Manley, Michael W., Jr.
    Apte, Udayan
    FASEB JOURNAL, 2016, 30
  • [37] Hepatocyte nuclear factor-4 is responsible for the liver-specific expression of the gene coding for hepatocyte growth factor-like protein
    Waltz, SE
    Gould, FK
    Air, EL
    McDowell, SA
    Degen, SJF
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (15) : 9024 - 9032
  • [38] Progressive loss of hepatocyte nuclear factor 4 alpha activity in chronic liver diseases in humans
    Gunewardena, Sumedha
    Huck, Ian
    Walesky, Chad
    Robarts, Dakota
    Weinman, Steven
    Apte, Udayan
    HEPATOLOGY, 2022, 76 (02) : 372 - 386
  • [39] Sirtuin 2 Prevents Liver Steatosis and Metabolic Disorders by Deacetylation of Hepatocyte Nuclear Factor 4α
    Ren, Huihui
    Hu, Fuqing
    Wang, Dan
    Kang, Xiaonan
    Feng, Xiaohui
    Zhang, Lu
    Zhou, Bowen
    Liu, Siyue
    Yuan, Gang
    HEPATOLOGY, 2021, 74 (02) : 723 - 740
  • [40] Liver-type fatty acid binding protein interacts with hepatocyte nuclear factor 4α
    McIntosh, Avery L.
    Petrescu, Anca D.
    Hostetler, Heather A.
    Kier, Ann B.
    Schroeder, Friedhelm
    FEBS LETTERS, 2013, 587 (23) : 3787 - 3791